0001567619-19-007317.txt : 20190320
0001567619-19-007317.hdr.sgml : 20190320
20190320173015
ACCESSION NUMBER: 0001567619-19-007317
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190318
FILED AS OF DATE: 20190320
DATE AS OF CHANGE: 20190320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NICOLS JOHN J
CENTRAL INDEX KEY: 0001238884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34705
FILM NUMBER: 19695378
MAIL ADDRESS:
STREET 1: ALBEMARLE CORP
STREET 2: 451 FLORIDA ST
CITY: BATON ROUGE
STATE: LA
ZIP: 70801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CODEXIS INC
CENTRAL INDEX KEY: 0001200375
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 710872999
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-421-8100
MAIL ADDRESS:
STREET 1: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2019-03-18
0
0001200375
CODEXIS INC
CDXS
0001238884
NICOLS JOHN J
C/O CODEXIS, INC.
200 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
President and CEO
Common Stock
2019-03-18
4
M
0
15072
3.46
A
1087751
D
Common Stock
2019-03-18
4
S
0
15072
20.9472
D
1072679
D
Common Stock
2019-03-19
4
M
0
40000
3.46
A
1112679
D
Common Stock
2019-03-19
4
S
0
40000
20.7876
D
1072679
D
Stock Option (Right to Buy)
3.46
2019-03-18
4
M
0
15072
0
D
2022-06-12
Common Stock
15072
215385
D
Stock Option (Right to Buy)
3.46
2019-03-19
4
M
0
40000
0.00
D
2022-06-12
Common Stock
40000
175385
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017.
This transaction was executed in multiple trades in prices ranging from $20.90 to $21.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $20.62 to $20.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The option is fully vested and exercisable.
/s/ Richard Sabalot, Attorney-in-Fact for John Nicols
2019-03-20